HN-0190

N/A

Report date: 2023/01/12 10:47:28
NME

Base Information

Drug NameHN-0190
Drug Alias NameHN0190HN-0190
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA-directed RNA polymerase inhibitors
TargetsRNA-directed RNA polymerase
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHuinuo Biomedical Technology (Hangzhou) Co LtdMedshine Discovery Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHuinuo Biomedical Technology (Hangzhou) Co LtdMedshine Discovery Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A